Es gab 50 kürzliche Insider-Transaktionen für KalVista Pharmaceuticals, Inc. (KALV), darunter 10 Käufe und 40 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf RSU Award und die gesamten Insider-Verkäufe auf $1.33M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Venrock Healthcare Capital Partners Iii, L.p., Palleiko Benjamin L, Yea Christopher. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — KALV
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-26 |
Venrock Healthcare Capital Partners Iii, L.p. |
10 Percent Owner |
Informierter Verkauf |
3,183 |
$19.12 |
$60.86K |
5,089,354 |
| 2026-03-25 |
Venrock Healthcare Capital Partners Iii, L.p. |
10 Percent Owner |
Informierter Verkauf |
160 |
$17.53 |
$2.8K |
5,129,340 |
| 2026-03-09 |
Palleiko Benjamin L |
Chief Executive Officer |
Informierter Verkauf |
6,693 |
$16.08 |
$107.63K |
451,815 |
| 2026-03-06 |
Palleiko Benjamin L |
Chief Executive Officer |
Optionsausübung (Verkauf) |
15,625 |
- |
- |
125,001 |
| 2026-02-23 |
Palleiko Benjamin L |
Chief Executive Officer |
Informierter Verkauf |
10,034 |
$15.57 |
$156.2K |
442,883 |
| 2026-02-23 |
Yea Christopher |
Chief Development Officer |
Informierter Verkauf |
4,347 |
$15.57 |
$67.67K |
226,701 |
| 2026-02-23 |
Piekos Brian |
Chief Financial Officer |
Informierter Verkauf |
1,767 |
$15.57 |
$27.51K |
13,762 |
| 2026-02-23 |
Sweeny Nicole |
Chief Commercial Officer |
Informierter Verkauf |
3,975 |
$15.57 |
$61.88K |
47,003 |
| 2026-02-23 |
Audhya Paul K. |
Chief Medical Officer |
Informierter Verkauf |
5,354 |
$15.57 |
$83.34K |
138,983 |
| 2026-02-22 |
Yea Christopher |
Chief Development Officer |
Optionsausübung (Verkauf) |
3,125 |
- |
- |
28,125 |
| 2026-02-22 |
Sweeny Nicole |
Chief Commercial Officer |
Optionsausübung (Verkauf) |
5,000 |
- |
- |
45,000 |
| 2026-02-22 |
Audhya Paul K. |
Chief Medical Officer |
Optionsausübung (Verkauf) |
5,000 |
- |
- |
45,000 |
| 2026-02-21 |
Palleiko Benjamin L |
Chief Executive Officer |
Optionsausübung (Verkauf) |
23,250 |
- |
- |
279,000 |
| 2026-02-21 |
Yea Christopher |
Chief Development Officer |
Optionsausübung (Verkauf) |
3,750 |
- |
- |
45,000 |
| 2026-02-21 |
Piekos Brian |
Chief Financial Officer |
Optionsausübung |
5,000 |
- |
- |
15,529 |
| 2026-02-21 |
Sweeny Nicole |
Chief Commercial Officer |
Optionsausübung |
6,250 |
- |
- |
45,978 |
| 2026-02-21 |
Audhya Paul K. |
Chief Medical Officer |
Optionsausübung (Verkauf) |
6,250 |
- |
- |
75,000 |
| 2026-02-18 |
Palleiko Benjamin L |
Chief Executive Officer |
Informierter Verkauf |
1,038 |
$15.00 |
$15.57K |
429,667 |
| 2026-02-18 |
Yea Christopher |
Chief Development Officer |
Informierter Verkauf |
1,109 |
$15.00 |
$16.64K |
224,173 |
| 2026-02-18 |
Audhya Paul K. |
Chief Medical Officer |
Informierter Verkauf |
1,163 |
$15.00 |
$17.45K |
133,087 |
| 2026-02-17 |
Palleiko Benjamin L |
Chief Executive Officer |
Optionsausübung (Verkauf) |
2,419 |
- |
- |
2,419 |
| 2026-02-17 |
Yea Christopher |
Chief Development Officer |
Optionsausübung (Verkauf) |
1,774 |
- |
- |
1,774 |
| 2026-02-17 |
Audhya Paul K. |
Chief Medical Officer |
Optionsausübung (Verkauf) |
2,419 |
- |
- |
2,419 |
| 2026-02-12 |
Palleiko Benjamin L |
Chief Executive Officer |
Informierter Verkauf |
3,354 |
$15.70 |
$52.66K |
428,286 |
| 2026-02-11 |
Palleiko Benjamin L |
Chief Executive Officer |
Optionsausübung (Verkauf) |
7,120 |
- |
- |
99,680 |
| 2026-01-16 |
Palleiko Benjamin L |
Chief Executive Officer |
RSU-Zuteilung |
325,000 |
- |
- |
325,000 |
| 2026-01-16 |
Piekos Brian |
Chief Financial Officer |
RSU-Zuteilung |
100,000 |
- |
- |
100,000 |
| 2026-01-16 |
Sweeny Nicole |
Chief Commercial Officer |
RSU-Zuteilung |
100,000 |
- |
- |
100,000 |
| 2026-01-16 |
Audhya Paul K. |
Chief Medical Officer |
RSU-Zuteilung |
100,000 |
- |
- |
100,000 |
| 2026-01-16 |
Arif Bilal |
Chief Operations Officer |
RSU-Zuteilung |
49,000 |
- |
- |
49,000 |
| 2025-12-08 |
Palleiko Benjamin L |
Chief Executive Officer |
Informierter Verkauf |
7,294 |
$16.51 |
$120.42K |
424,520 |
| 2025-12-06 |
Palleiko Benjamin L |
Chief Executive Officer |
Optionsausübung (Verkauf) |
15,625 |
- |
- |
140,626 |
| 2025-11-24 |
Palleiko Benjamin L |
Chief Executive Officer |
Informierter Verkauf |
10,940 |
$13.45 |
$147.15K |
416,189 |
| 2025-11-24 |
Yea Christopher |
Chief Development Officer |
Informierter Verkauf |
4,331 |
$13.45 |
$58.26K |
223,508 |
| 2025-11-24 |
Piekos Brian |
Chief Financial Officer |
Informierter Verkauf |
4,471 |
$13.45 |
$60.14K |
10,529 |
| 2025-11-24 |
Audhya Paul K. |
Chief Medical Officer |
Informierter Verkauf |
5,296 |
$13.45 |
$71.24K |
131,831 |
| 2025-11-24 |
Sweeny Nicole |
Chief Commercial Officer |
Informierter Verkauf |
3,813 |
$13.45 |
$51.29K |
39,728 |
| 2025-11-22 |
Yea Christopher |
Chief Development Officer |
Optionsausübung (Verkauf) |
3,125 |
- |
- |
31,250 |
| 2025-11-22 |
Audhya Paul K. |
Chief Medical Officer |
Optionsausübung (Verkauf) |
5,000 |
- |
- |
50,000 |
| 2025-11-22 |
Sweeny Nicole |
Chief Commercial Officer |
Optionsausübung |
5,000 |
- |
- |
43,541 |
| 2025-11-21 |
Palleiko Benjamin L |
Chief Executive Officer |
Optionsausübung (Verkauf) |
23,250 |
- |
- |
302,250 |
| 2025-11-21 |
Yea Christopher |
Chief Development Officer |
Optionsausübung (Verkauf) |
3,750 |
- |
- |
48,750 |
| 2025-11-21 |
Piekos Brian |
Chief Financial Officer |
Optionsausübung |
15,000 |
- |
- |
15,000 |
| 2025-11-21 |
Audhya Paul K. |
Chief Medical Officer |
Optionsausübung (Verkauf) |
6,250 |
- |
- |
81,250 |
| 2025-11-21 |
Sweeny Nicole |
Chief Commercial Officer |
Optionsausübung |
6,250 |
- |
- |
38,541 |
| 2025-11-20 |
Yea Christopher |
Chief Development Officer |
Optionsausübung (Verkauf) |
87,390 |
$0.00 |
$375.78 |
- |
| 2025-11-18 |
Palleiko Benjamin L |
Chief Executive Officer |
Informierter Verkauf |
4,466 |
$14.48 |
$64.67K |
403,879 |
| 2025-11-18 |
Yea Christopher |
Chief Development Officer |
Informierter Verkauf |
2,683 |
$14.48 |
$38.85K |
133,574 |
| 2025-11-18 |
Audhya Paul K. |
Chief Medical Officer |
Informierter Verkauf |
3,075 |
$14.48 |
$44.52K |
125,877 |
| 2025-11-17 |
Palleiko Benjamin L |
Chief Executive Officer |
Optionsausübung (Verkauf) |
6,945 |
- |
- |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
